Corcept Therapeutics Incorporated (CORT) — Capital Reinvestment Ratio
Corcept Therapeutics Incorporated (CORT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($38.45 Million) in capital expenditures ($50.00K). See CORT equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Corcept Therapeutics Incorporated Capital Reinvestment Ratio (2015–2025)
This chart tracks Corcept Therapeutics Incorporated's Capital Reinvestment Ratio across 11 annual periods. Check Corcept Therapeutics Incorporated investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Capital Reinvestment Ratio for Corcept Therapeutics Incorporated from 2015 to 2025. For live market cap and broader valuation context, see Corcept Therapeutics Incorporated (CORT) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $142.00 Million | $211.00K | ▼ -86.4% |
| 2024 | 0.01x | $198.07 Million | $2.17 Million | ▲ +902.2% |
| 2023 | 0.00x | $127.04 Million | $139.00K | ▼ -68.1% |
| 2022 | 0.00x | $120.32 Million | $413.00K | ▲ +22.9% |
| 2021 | 0.00x | $167.89 Million | $469.00K | ▼ -65.7% |
| 2020 | 0.01x | $151.97 Million | $1.24 Million | ▲ +1.9% |
| 2019 | 0.01x | $136.12 Million | $1.09 Million | ▲ +210.2% |
| 2018 | 0.00x | $115.67 Million | $298.00K | ▼ -62.5% |
| 2017 | 0.01x | $60.94 Million | $419.00K | ▼ -34.8% |
| 2016 | 0.01x | $18.39 Million | $194.00K | ▲ +94.2% |
| 2015 | 0.01x | $3.13 Million | $17.00K | — |